Indications and uses
to reduce the duration of the common cold. reduces the severity of cold symptoms: cough, sore throat, nasal congestion post nasal drip and/or hoarseness. supports immune system health.
Cold-EEZE
- Manufacturer
- ProPhase Labs, Inc. | Pharmaloz Manufacturing, Inc. | Blispak, Inc.
- Effective date
- 2013-08-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:04:59
Label at a glance#
ProductCold-EEZE PLUS Immune Support
Active ingredientZinc Gluconate, ROSA CANINA LEAF, ECHINACEA PURPUREA
Label structure9 sections
Dosage and administration
Take Cold-EEZE ® Plus Immune Support QuickMelts ® when you have cold symptoms. Adults: Dissolve entire tablet in mouth. Do not chew. Do not swallow whole. Take 1 tablet at the onset of symptoms. Repeat every 2-4 hours as needed until all symptoms subside. Do not eat or drink for 15 minutes after use, otherwise, drink plenty of fluids. Recommended daily dose is 6 tablets for adults. For individuals under the age of...
Storage and handling
Do not take on an empty stomach to avoid possible minor stomach upset. Echinacea might cause a slight tingling sensation on the tongue. Store in a cool and dry place.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredient (per tablet) | Purpose |
|---|---|
| Zincum Gluconicum 1X | Cold Remedy |
| Rosa Canina L. (Rose Hip) 1X | Promotes Immune support |
| Echinacea Purpurea Extract 2X | Promotes Immune support |
Uses
- to reduce the duration of the common cold.
- reduces the severity of cold symptoms: cough, sore throat, nasal congestion post nasal drip and/or hoarseness.
- supports immune system health.
Warnings
Ask a doctor before use if you
- are taking minocycline, doxycycline, tetracycline or are on Coumadin therapy, as zinc treatment may inhibit the absorption of these medicines.
- are under medical supervision for diabetes or have a skin condition called pemphigus vulgaris or have multiple sclerosis (MS), rheumatoid arthritis (RA), or an auto-immune condition.
OTC - STOP USE SECTION
Stop use and ask your healthcare practitioner if symptoms persist beyond 7 days.
OTC - DO NOT USE SECTION
Cold-EEZE® Plus Immune Support QuickMelts® is a combination product formulated to help you to reduce the duration of the common cold and its symptoms and promote immune system health. It is insufficient treatment for Influenza or Allergies.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast feeding, ask a healthcare practitioner before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
Directions
- Take Cold-EEZE® Plus Immune Support QuickMelts® when you have cold symptoms.
- Adults:
- Dissolve entire tablet in mouth. Do not chew. Do not swallow whole.
- Take 1 tablet at the onset of symptoms.
- Repeat every 2-4 hours as needed until all symptoms subside.
- Do not eat or drink for 15 minutes after use, otherwise, drink plenty of fluids.
- Recommended daily dose is 6 tablets for adults.
- For individuals under the age of 18, consult a healthcare practitioner before use.
Other information
- Do not take on an empty stomach to avoid possible minor stomach upset.
- Echinacea might cause a slight tingling sensation on the tongue.
- Store in a cool and dry place.
Other ingredients
beta carotene, crospovidone, glycine, magnesium stearate, malic acid, mannitol, microcrystalline cellulose, natural menthol flavor, natural orange flavor, polyethylene glycol, silicon dioxide, sodium lauryl sulfate sodium starch glycolate, stevia, sucralose, talc.
SPL UNCLASSIFIED SECTION
Distributed by:
ProPhase Labs, Inc.
P.O. Box 1349, Doylestown
PA 18901
PRINCIPAL DISPLAY PANEL - 24 Tablet Package
NEW QuickMelts®
GREAT
TASTE
Cold-EEZE®
Zinc Gluconate Glycine
COLD REMEDY
Plus Natural
Immune Support
- Shortens Your Cold, Works Faster
- Promotes Immune Health,
Antioxidant Support- Rose Hips: Rich in Natural Vitamin C
- Echinacea
24 QuickMelts®
Homeopathic
Natural
Orange Flavor
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61941-0223-4 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e45c-cd31-e053-dbdaa90ab51a | Cold-EEZE ® PLUS Immune Support |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61941-0223-1 | Cold-EEZE PLUS Immune Support | 6 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 6 | 1 | |
| 61941-0223-4 | Cold-EEZE PLUS Immune Support | 4 in 1 PACKAGE | TABLET, ORALLY DISINTEGRATING | 4 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61941-0223 | COLD-EEZE PLUS IMMUNE SUPPORT (ZINC GLUCONATE, ROSA CANINA LEAF, AND ECHINACEA PURPUREA) TABLET, ORALLY DISINTEGRATING [PROPHASE LABS, INC.] | 1 | Legacy NDC, 2 package rows | 20130928_d75c93c1-314b-484b-b8ad-29def45d0e0e.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ECHINACEA PURPUREA | ACTIVE INGREDIENT | QI7G114Y98 | 1 | |
| ROSA CANINA LEAF | ACTIVE INGREDIENT | J3N2Z889QP | 1 | |
| Zinc Gluconate | ACTIVE INGREDIENT | U6WSN5SQ1Z | 1 | |
| ECHINACEA PURPUREA | ACTIVE MOIETY | QI7G114Y98 | 1 | |
| ROSA CANINA LEAF | ACTIVE MOIETY | J3N2Z889QP | 1 | |
| Zinc Cation | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| .BETA.-CAROTENE | INACTIVE INGREDIENT | 01YAE03M7J | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | 1 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| MALIC ACID | INACTIVE INGREDIENT | 817L1N4CKP | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | 1 | |
| MENTHOL | INACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| ORANGE | INACTIVE INGREDIENT | 5EVU04N5QU | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 1 | |
| STEVIA REBAUDIUNA LEAF | INACTIVE INGREDIENT | 6TC6NN0876 | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Products#
Every source-derived product name is available through these pages.
- Cold-EEZE PLUS Immune Support
- Zinc Gluconate, ROSA CANINA LEAF, and ECHINACEA PURPUREA
- Zinc Gluconate
- Zinc Cation
- ROSA CANINA LEAF
- ECHINACEA PURPUREA
- GLYCINE
- .BETA.-CAROTENE
- CROSPOVIDONE
- MAGNESIUM STEARATE
- MALIC ACID
- MANNITOL
- CELLULOSE, MICROCRYSTALLINE
- MENTHOL
- ORANGE
- POLYETHYLENE GLYCOLS
- SILICON DIOXIDE
- SODIUM LAURYL SULFATE
- SODIUM STARCH GLYCOLATE TYPE A POTATO
- STEVIA REBAUDIUNA LEAF
- SUCRALOSE
- TALC
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 61941-0223 | 61941-0223-1, 61941-0223-4 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | PASTE, DENTIFRICE / DENTAL | 1.4 %w/w | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, EFFERVESCENT / ORAL | 1080 mg | ||
| TALC | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, EXTENDED RELEASE / ORAL | 160 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET / ORAL | 3391 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | POWDER, FOR SOLUTION / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SUSPENSION / ORAL | 383 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | POWDER, FOR SUSPENSION / INTRAMUSCULAR | 6.75 %w/v | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | TABLET, CHEWABLE / ORAL | 3726 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | POWDER / RESPIRATORY (INHALATION) | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, DELAYED RELEASE / ORAL | 2043 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 105 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | DROPS / ORAL | NA | ||
| MANNITOL | MANNITOL | 3OWL53L36A | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | TABLET, CHEWABLE / ORAL | 267 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, SOLUTION / INTRAVENOUS | 15400 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | SOAP / TOPICAL | 0.75 %w/w | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET / ORAL | 0.58 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | WAFER / ORAL | 642 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, CHEWABLE / ORAL | 6 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | INHALANT / NASAL | 32 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | SHAMPOO, SUSPENSION / TOPICAL | 40 %w/v | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SOLUTION / INTRAVENOUS | 15400 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| MALIC ACID | MALIC ACID | 817L1N4CKP | SOLUTION / ORAL | 16760 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | DROPS / OPHTHALMIC | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| MALIC ACID | MALIC ACID | 817L1N4CKP | TABLET / ORAL | 20 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | TABLET, ORALLY DISINTEGRATING / ORAL | 14 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | FILM, SOLUBLE / ORAL | 33 mg | ||
| MENTHOL | MENTHOL | L7T10EIP3A | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | POWDER / VAGINAL | 3 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | GUM, CHEWING / BUCCAL | 70 mg | ||
| MANNITOL | MANNITOL | 3OWL53L36A | SUSPENSION / OPHTHALMIC | 9 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| .BETA.-CAROTENE | BETA CAROTENE | 01YAE03M7J | CREAM / TOPICAL | NA | ||
| MANNITOL | MANNITOL | 3OWL53L36A | INJECTION, POWDER, FOR SOLUTION / PARENTERAL | 200 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8c9e0e83-058b-4f5a-899f-03a0f80033c0 | d75c93c1-314b-484b-b8ad-29def45d0e0e | 2013-08-22 | Warnings | 8c9e0e83-058b-4f5a-899f-03a0f80033c0 d75c93c1-314b-484b-b8ad-29def45d0e0e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.